Utility Estimation of Health Status of Cancer Patients by Mapping for Cost-Utility Analysis

Authors

  • Ameri , Hossein Assistance Professor, Health Policy and Management Research Center, Department of Healthcare Management, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
  • Erfani Khanghahi , Masoumeh Assistant Professor, Department of Educational Management, School of Management and Accounting, Islamic Azad University, Yadegar-e Imam Khomeini Branch, Shahre Rey, Tehran, Iran
  • Mortezaei , Ali Reza MSc student of Nursing, School of Nursing and Midwifery, Shiraz University of Medical Sciences, Shiraz, Iran
  • Rajabi , Marziyeh MSc student of Health Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Abstract:

Background: It is important to obtain accurate information about the preferences of people for measuring quality-adjusted life years (QALYs), because it is necessary for cost-utility analysis. In this regard, mapping is a method to access this information. Therefore, the purpose of this study was to map Functional Assessment of Cancer Therapy – General (FACT-G) onto Short Form Six Dimension (SF-6D) in breast cancer patients to provide appropriate conditions for a detailed cost-utility analysis. Methods: This descriptive analytical study was conducted on 416 patients with breast cancer. The SF-6D and FACT-G questionnaires were completed for patients selected by consecutive sampling from the Imam Khomeini Cancer Institute in Tehran in 2018. The Ordinary Least Squares model was used to estimate the value of utility and the models' goodness of fit was evaluated using R2. In addition, models' predictive performance was assessed by Mean Absolute Error (MAE), Root Mean Square Error (RMSE), and Minimal Important Difference (MID) conducted between the observed and predicted SF-6D values. Models were validated using a 10-fold cross validation method. Results: Given the criteria of goodness of fit, model 2 was the best (R2 = 41.19 %). Moreover, findings of the predictive performance of models showed that model 2 was the best (MAE = 0.06943, RMSE = 0.09031, and MID = 0.0003). Conclusions: Findings showed that the developed algorithm had a good predictive ability. So, it can enable the policymakers and researchers to convert cancer-specific health-related quality of life instruments to preference-based instruments.  

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

neonatal screening: cost-utility analysis for galactosemia

background: galactosemia is a congenital metabolic disorder that can damage the health of a newborn. screening is an important step to prevent and treat this condition. due to increasing health care costs and limited financial resources of health systems, the most suitable economic analysis tool should be applied. the aim of this study was to analyze the cost-utility of neonatal screening progr...

full text

Diagnostic Utility of miRNAs in Cancer

Cancer is the one of most prevalent and leading causes of death in the world. Current ad­vancements in technology improve the understanding of the pathogenesis and pathology of cancers. But, due to enlarging mortality rates, poor prognosis, and lacunae in clinical early predictive biomarkers provide an important momentum to investigate novel early diagnos­tic/prognostic markers and spec...

full text

Diagnostic Utility of miRNAs in Cancer

Cancer is the one of most prevalent and leading causes of death in the world. Current ad­vancements in technology improve the understanding of the pathogenesis and pathology of cancers. But, due to enlarging mortality rates, poor prognosis, and lacunae in clinical early predictive biomarkers provide an important momentum to investigate novel early diagnos­tic/prognostic markers and spec...

full text

Cost-utility analysis of treatments for stage IB cervical cancer

OBJECTIVE To analyze the cost-utility of two common clinical practices for stage IB cervical cancer patients from provider and societal viewpoints. METHODS A DECISION TREE MODEL WAS CONDUCTED TO EXAMINE VALUE FOR EXPENDITURE BETWEEN THE FOLLOWING: (1) radical hysterectomy with pelvic lymph node dissection (RHPLND) with or without postoperative adjuvant therapy according to the risk of recurre...

full text

A cost–utility analysis

Neurology S. Claiborne Johnston, Daryl R. Gress and James G. Kahn Which unruptured cerebral aneurysms should be treated?: A cost–utility analysis This information is current as of January 25, 2006 http://www.neurology.org/cgi/content/full/52/9/1806 located on the World Wide Web at: The online version of this article, along with updated information and services, is Print ISSN: 0028-3878. Online ...

full text

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis in Iran

Background: Teriparatide is a new agent serves as a treatment of choice for severe post-menopausal osteoporotic patients who are at a high risk of fracture or have failed or been intolerant of previous osteoporosis therapy. The objective of this study is estimating the cost-utility of Teriparatide compared with no treatment from health system perspective in Iran. Method: A microsimulation...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 4  issue 1

pages  2- 10

publication date 2019-06

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

No Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023